Inventor · disambiguated record
Michael Zalutsky
Also filed as: ZALUTSKY MICHAEL · ZALUTSKY MICHAEL R · ZALUTSKY MICHAEL ROD
9 granted patents·15 pending applications·202 citations·filing 1988–2024
87Inventor score
Top patents by PatentIndex Score
24 records- 0194US5624659AMethod of treating brain tumors expressing tenascinUNIV DUKE·Filed 1995·Granted Apr 29, 1997·144 cites·21 claims
- 0287US11813340B2PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapyUNIV JOHNS HOPKINS·Filed 2019·Granted Nov 14, 2023·2 cites·31 claims
- 0379US6426400B1Radioconjugation of internalizing antibodiesUNIV DUKE·Filed 2000·Granted Jul 30, 2002·9 cites·16 claims
- 0478US12233137B1PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapyUNIV JOHNS HOPKINS·Filed 2023·Granted Feb 25, 2025·0 cites·20 claims
- 0577US9839704B2Prosthetic compounds for labeling internalizing biomoleculesUNIV DUKE·Filed 2014·Granted Dec 12, 2017·2 cites·19 claims
- 0677US2025177580A1Psma targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapyUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 0775US2024140971A1Psma targeted radiohalogenated ureas for cancer radiotherapyUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 0874US2025073359A1Radiolabeled biomolecules and their useUNIV DUKE·Filed 2024·Application pending·0 cites
- 0968US5558852AMethods of treating melanomas and gliomas with monoclonal antibody Me1-14UNIV DUKE·Filed 1994·Granted Sep 24, 1996·34 cites·28 claims
- 1067US2011217231A1Anti-tenascin monoclonal antibody therapy for lymphomaUNIV DUKE·Filed 2007·Application pending·0 cites
- 1162US2006257317A1Combination therapy in the treatment of cancerUNIV DUKE·Filed 2006·Application pending·0 cites
- 1260US2010047167A1Combination therapy in the treatment of cancerUNIV DUKE·Filed 2009·Application pending·0 cites
- 1358US2024307561A1Radiolabeled parp inhibitor conjugates for cancer treatmentUNIV DUKE·Filed 2022·Application pending·0 cites
- 1453US2024358867A1Reagents for site-specific labeling of proteins with radiohalogens, and methods of making and using the sameUNIV DUKE·Filed 2022·Application pending·0 cites
- 1552US2020188541A1Radiolabeled biomolecules and their useUNIV DUKE·Filed 2018·Application pending·0 cites
- 1651US2023002293A1Radiohalogen prosthetic moieties and radiolabeled biomoleculesUNIV DUKE·Filed 2020·Application pending·0 cites
- 1750US5302700ARadiohalogenation conjugate technologyUNIV DUKE·Filed 1988·Granted Apr 12, 1994·10 cites·3 claims
- 1850US2022226513A118f-radiolabeled biomoleculesUNIV DUKE·Filed 2020·Application pending·0 cites
- 1946US2002187100A1Anti-tenascin monoclonal antibody therapy for lymphomaFiled 2001·Application pending·0 cites
- 2045US2020231614A1Psma targeted radiohalogenated ureas for cancer radiotherapyUNIV JOHNS HOPKINS·Filed 2016·Application pending·0 cites
- 2143US2006127311A1Radiation dosimetry and blocking antibodies and methods and uses therefor in the treatment of cancerUNIV DUKE·Filed 2005·Application pending·0 cites
- 2236US8337810B2Stabilized compositions and methods for radiolabeling pharmaceuticals with alpha-particle emittersZALUTSKY MICHAEL ROD·Filed 2006·Granted Dec 25, 2012·0 cites·25 claims
- 2332US2012270812A1Compositions, methods, and kits for determining an alkyl transferaseZALUTSKY MICHAEL R·Filed 2010·Application pending·0 cites
- 2431US6998106B1Radioconjugation of internalizing antibodiesUNIV DUKE·Filed 1998·Granted Feb 14, 2006·1 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Michael Zalutsky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →